Search - tctmd.com

Displaying 21 - 40 of 151

Sort: Relevancy | Date

Presentation THT 2024

Impact of Conduction System Pacing on LV Function (PV Loops)

Presenter: Petr Neuzil

March 05, 2024

Presentation THT 2024

DoReMe: Are Inotropes Helpful or Harmful?

Presenter: Benjamin Hibbert

March 05, 2024

Presentation THT 2024

IV Diltiazem Use in Patients with Atrial Fibrillation and Systolic Dysfunction

Presenter: Joseph Ibrahim

March 05, 2024

Presentation THT 2024

Neuromodulation by Atrioventricular Interval Modulation (AVIM) Therapy

Presenter: Karl-Heinz Kuck

March 05, 2024

Presentation THT 2024

Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps

Presenter: Hidetaka Morita

March 05, 2024

Presentation THT Abstracts 2024

IV Diltiazem Use in Patients with Atrial Fibrillation and Systolic Dysfunction

Presenter: Joseph Ibrahim

March 04, 2024

Presentation THT 2024

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Presenter: Rebecca T. Hahn

March 04, 2024

Presentation Miami Valves 2024

Temporary A-V Sequential Pacing System

Presenter: Eduardo de Marchena

February 03, 2024

Presentation Miami Valves 2024

Updates in Cardiac Resynchronization

Presenter: Alex Velasquez

February 01, 2024

Presentation Controversies and Advances 2023

Are You Kidding Me? Traditional CRT is Irreplaceable

Presenter: Archana Ramireddy

December 01, 2023

Presentation Controversies and Advances 2023

The Future Belongs to Conduction System Pacing

Presenter: Eric D. Braunstein

November 30, 2023

Presentation Controversies and Advances 2023

Debate: Safety of Sports for Young Patients with Inherited Arrhythmia Syndromes

Presenter: Sumeet S. Chugh

November 30, 2023

Presentation AHA 2023

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Presenter: Jeff Healey

November 16, 2023

Presentation AHA 2023

AZALEA-TIMI 71

Presenter: Christian T. Ruff

November 15, 2023

Presentation AHA 2023

Efficacy and safety of anticoagulation with edoxaban in patients with Atrial high rate-episodes (AHRE) durations ≥ 24 hours - The NOAH-AFNET 6 trial

Presenter: Nina Becher

November 14, 2023

Presentation TCT 2023

New Onset Atrial Fibrillation After PFO Closure: How to Manage?

Presenter: Harsimran Singh

October 26, 2023

Presentation TCT 2023

High-risk PFO in a Patient With AF and Ischemic Stroke: Is There a Role for PFO Closure?

Presenter: Safwan Kassas

October 26, 2023

Presentation TCT 2023

AFib Screening in Older Patients With Embolic Stroke and PFO: How and for How Long?

Presenter: Barry Love

October 26, 2023

Presentation TCT 2023

My 47-Year-Old PFO/Stroke Patient Had a Brief Run of AF on Monitoring: Now What?

Presenter: Sameer Gafoor

October 26, 2023

Presentation TCT 2023

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

Presenter: Edip Gurol

October 26, 2023

Advertisement

Impact of Conduction System Pacing on LV Function (PV Loops)

DoReMe: Are Inotropes Helpful or Harmful?

IV Diltiazem Use in Patients with Atrial Fibrillation and Systolic Dysfunction

Neuromodulation by Atrioventricular Interval Modulation (AVIM) Therapy

Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps

IV Diltiazem Use in Patients with Atrial Fibrillation and Systolic Dysfunction

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Temporary A-V Sequential Pacing System

Updates in Cardiac Resynchronization

Are You Kidding Me? Traditional CRT is Irreplaceable

The Future Belongs to Conduction System Pacing

Debate: Safety of Sports for Young Patients with Inherited Arrhythmia Syndromes

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

AZALEA-TIMI 71

Efficacy and safety of anticoagulation with edoxaban in patients with Atrial high rate-episodes (AHRE) durations ≥ 24 hours - The NOAH-AFNET 6 trial

New Onset Atrial Fibrillation After PFO Closure: How to Manage?

High-risk PFO in a Patient With AF and Ischemic Stroke: Is There a Role for PFO Closure?

AFib Screening in Older Patients With Embolic Stroke and PFO: How and for How Long?

My 47-Year-Old PFO/Stroke Patient Had a Brief Run of AF on Monitoring: Now What?

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content